ANSLEY POAGUE: Open Payments
NPI 1942724919 · COLQUITT, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$224 in 12 payments from 7 companies in 2025. Trend: 2023 $396 · 2024 $403 · 2025 $224
Food & beverage: $224
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $119 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
| GlaxoSmithKline, LLC. | 1 | $19 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
| ABBVIE INC. | 1 | $17 |
| Dexcom, Inc. | 1 | $16 |
| Lilly USA, LLC | 1 | $14 |
Products named: Rybelsus, Wegovy, Ozempic, TRELEGY ELLIPTA, AIRSUPRA, VRAYLAR, Dexcom G6 Transmitter, MOUNJARO.
Industry payments across GA — which companies pay providers there.
